Ref ID: 18625
Author:
S. Shiryaev, A. Chukhlovin, M. Popova, I. Neustroeva,
L. Zubarovskaya, B. Afanasyev
Author address:
R.M.Gorbacheva Memorial Institute of Children Hematology
and Transplantology (St. Petersburg, RU)
Full conference title:
Annual Meeting of the EBMT, 37th
Abstract:
Introduction: HSV is a signifi cant infectious pathogen in alloHSCT recipients. Organ and tissue damage, duration and intensity of immunosupression are among main triggering factors of
HSV reactivation. We supposed that allo-HSCT with reducedintensity conditioning (RIC) would decrease HSV reactivation
due to reduced organ and tissue damage.
Objectives: studying incidence of HSV reactivation in allo-HSCT
with myeloablative conditioning (MAC) vs RIC, and studies of
correlations between HSV reactivation and incidence/severity
complications in allo-HSCT.
Patient and methods. Fifty-four children and adolescents up to
21 years old with ALL and AML underwent matched related and
unrelated HSCT (either bone marrow or peripheral stem cells)
with MAC (n=31) and RIC (n=23) were included in the study.
HSV reactivation (HSV+) was detected by means of qualitative
PCR in blood, performed weekly both before and after engraftment until d+30. Toxic complications (hepatitis, neurological disorders etc) were determined according to appropriate criteria.
Results: We compared the incidence some toxic complications
(mucositis, severe mucositis, hepatitis, neurological disorders), occurrence of acute graft-versus-host-disease (aGVHD),
including aGVHD III-IV, intestinal aGVHD, hepatic aGVHD,
incidence of infectious complications, including aspergillosis
and sepsis in the following groups: “œallo-HSCT HSV+” vs “œalloHSCT HSV-“, “œMAC HSCT HSV+ vs MAC HSCT HSV-“, “œRIC
HSCT HSV+ vs RIC HSCT HSV-“, “œMAC HSCT HSV+ vs RIC
HSV+”, “œMAC HSCT HSV- vs RIC HSCT HSV-“. Observed difference in evaluated groups haven’t any statistical signifi cance,
only a strong tend to more frequent rate of infectious complications in “œallo-HSCT HSV+” group vs “œallo-HSCT HSV-“œ group
were observed, 88% and 39% respectively (p=0,057).
Conclusion: HSV reactivation may have some relations with
transplant-related morbidity, especially with other infections.
Abstract Number: P813
Conference Year: 2011
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a